Rheumatoid arthritis associated with eosinophilia.
D000368:Aged; D000888:Antibodies, Anti-Idiotypic / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000276:immunology; D001241:Aspirin / Q000627:therapeutic use; D003165:Complement System Proteins / Q000032:analysis; D004802:Eosinophilia / Q000150:complications* / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D004804:Eosinophils; D005260:Female; D005455:Fluorescent Antibody Technique; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007073:Immunoglobulin E / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007841:Latex Fixation Tests; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D010998:Pleurisy / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D011859:Radiography; D012215:Rheumatic Nodule / Q000150:complications; D013585:Synovitis / Q000473:pathology; D013997:Time Factors; D014652:Vascular Diseases / Q000150:complications
D000888:Antibodies, Anti-Idiotypic; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007073:Immunoglobulin E; D006046:Gold; D003165:Complement System Proteins; D001241:Aspirin; D011241:Prednisone